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Table 1 First- and second-line antiretroviral therapy regimens in use in TREAT Asia and IeDEA Southern Africa
Site Country Nationally recommended
paediatric first-line ART
regimen*
Nationally recommended
paediatric second-line ART
regimen after NNRTI
Most commonly used
second-line regimen in
current site cohort
TREAT Asia
National Center for HIV, AIDS,
Dermatology, and Sexually
Transmitted Infections
Cambodia d4T or AZT+3TC+NVP or EFV
If NNRTI exposure:
d4T+3TC+LPV/r
ABC+ ddI+LPV/r ABC+3TC+LPV/r
Beijing Ditan Hospital China d4T or AZT+3TC+NVP or EFV
If NNRTI exposure:
AZT+3TC+LPV/r
ABC+3TC+AZT+LPV/r ABC+3TC+AZT+LPV/r
YRG Centre for AIDS Research
and Education
India d4T or AZT+3TC+NVP or EFV ABC+ddI+3TC+LPV/r TDF or ddI+3TC or FTC+LPV/
r
Cipto Mangunkusumo Hospital Indonesia d4T or AZT+3TC+NVP or EFV ddI+3TC+LPV/r ddI+3TC+LPV/r
Hospital Kuala Lumpur Malaysia <3yr:
AZT+3TC or ddI+NVP
≥3yr:
AZT+3TC or ddI+EFV
2 new NRTI+LPV/r d4T+3TC+LPV/r
Hospital Likas Malaysia <3yr:
AZT+3TC or ddI+NVP
≥3yr:
AZT+3TC or ddI+EFV
2 new NRTI+LPV/r d4T+ddI+LPV/r
Hospital Penang Malaysia <3yr:
AZT+3TC or ddI+NVP
≥3yr:
AZT+3TC or ddI+EFV
2 new NRTI+LPV/r –
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Hospital Raja Perempuan Zainab Malaysia <3yr:
AZT+3TC or ddI+NVP
≥3yr:
AZT+3TC or ddI+EFV
2 new NRTI+LPV/r d4T+ddI+LPV/r
Chiang Mai University Medical
Centre
Thailand d4T or AZT+3TC+NVP or EFV ddI+ABC or 3TC+PI/r AZT+3TC+LPV/r
Chiang Rai Regional Hospital Thailand d4T or AZT+3TC+NVP or EFV ddI+ABC or 3TC+PI/r AZT+3TC+LPV/r
HIV-NAT Thailand d4T or AZT+3TC+NVP or EFV ddI+ABC or 3TC+PI/r AZT+3TC+LPV/r
Khon Kaen University Medical
Centre
Thailand d4T or AZT+3TC+NVP or EFV ddI+ABC or 3TC+PI/r AZT+ddI+LPV/r
Siriraj Hospital Thailand d4T or AZT+3TC+NVP or EFV ddI+ABC or 3TC+PI/r AZT+ddI+LPV/r
Children’s Hospital 1 Vietnam d4T+3TC+NVP ABC+ddI+LPV/r –
Children’s Hospital 2 Vietnam d4T+3TC+NVP ABC+ddI+LPV/r ABC+ddI+LPV/r
National Hospital of Paediatrics Vietnam d4T+3TC+NVP ABC+ddI+LPV/r ABC+ddI+LPV/r
IeDEA Southern Africa
Lighthouse Clinic Malawi d4T+3TC+NVP ABC+ddI+LPV/r AZT+3TC+LPV/r
Paediatric Day Hospital, Maputo Mozambique d4T or AZT+3TC+NVP or EFV
If NNRTI exposure:
d4T or AZT+3TC+LPV/r
ABC+ddI+LPV/r None
Rahima Moosa Mother and Child
Hospital
South Africa <3yr/10kg:
d4T+3TC+LPV/r
>3yr/10kg:
d4T+3TC+EFV
AZT+ddI+LPV/r ABC+3TC+LPV/r
Gugulethu Community Health
Centre
South Africa <3yr/10kg:
d4T+3TC+LPV/r
>3yr/10kg:
d4T+3TC+EFV
AZT+ddI+LPV/r AZT+ddI+EFV or LPV/r ABC
+3TC+LPV/r
Harriet Shezi Clinic South Africa <3yr/10kg:
d4T+3TC+LPV/r
>3yr/10kg:
d4T+3TC+EFV
AZT+ddI+LPV/r AZT+ddI+LPV/r
Khayelitsha Community Health
Centre
South Africa <3yr/10kg:
d4T+3TC+LPV/r
>3yr/10kg:
d4T+3TC+EFV
AZT+ddI+LPV/r AZT+ddI+LPV/r
McCord Hospital South Africa <3yr/10kg:
d4T+3TC+LPV/r
>3yr/10kg:
d4T+3TC+EFV
AZT+ddI+LPV/r AZT+ddI+LPV/r
Red Cross Children’s Hospital South Africa <3yr/10kg:
d4T+3TC+LPV/r
>3yr/10kg:
d4T+3TC+EFV
AZT+ddI+LPV/r AZT+ddI+EFV
Tygerberg Hospital South Africa <3yr/10kg:
d4T+3TC+LPV/r
>3yr/10kg:
d4T+3TC+EFV
AZT+ddI+LPV/r AZT+ddI+LPV/r
Newlands Clinic Zimbabwe AZT+3TC+NVP ddI+3TC+LPV/r d4T+3TC+NVP
*Content reflects current recommendations at the time of the survey. WHO first-line regimen recommendations at the time of the survey included two NRTIs
with one NNRTI or two NRTIs with one PI/r if the infant had previous NNRTI exposure [10,17]; second-line regimen recommendations after NNRTI failure included
two NRTIs with one PI/r or unboosted nelfinavir in limited circumstances.
d4T - stavudine; AZT - zidovudine; 3TC - lamivudine; NVP - nevirapine; EFV - efavirenz; ABC - abacavir; ddI - didanosine; LPV/r - ritonavir-boosted lopinavir; TDF -
tenofovir; FTC - emtricitabine; NRTI - nucleoside reverse transcriptase inhibitor; NNRTI - non-nucleoside reverse transcriptase inhibitor.
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